Everyone must have access to affordable and quality health care: Regence BlueCross BlueShield

The following is a statement from Mark Ganz, president and chief executive officer of Regence BlueCross BlueShield:

"These are extraordinary times. Our nation is in the midst of a pivotal conversation about health care reform. I applaud our nation's leaders for making this difficult issue a priority.

"This August we saw an unfortunate polarization of our country. Some of the rhetoric turned quite ugly. The end result has led to confusion and misinformation--none of which moves the discussion forward.

"We cannot allow such an atmosphere to cost our nation this chance to make lasting change. There is already broad agreement on key reforms: Everyone must have affordable coverage and access to quality care; insurers must drop pre-existing barriers to coverage; medical care must become more efficient and economical; and the entire system must be simpler and more transparent. Regence has advocated for these changes for years.

"Like many Americans, Regence has questions about specific elements of the reform proposals, including how to pay for them, but our deep commitment to improving the system is unwavering.

"We are devoted to real health care reform that provides meaningful coverage to all Americans, addresses the fundamental cost drivers that make coverage increasingly unaffordable in both the public and private sector, and ensures systemic and broader economic sustainability for our nation."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide may reduce smoking risks for diabetes patients